Aeva Stock Rises 26.8% After Announcing 4D LiDAR Integration with NvidiaDrive Hyperion
Equity futures were mostly unchanged following broad gains during the day as energy and defense stocks were among the leaders after a dramatic weekend in geopolitics. The United States captured Venezuelan President Nicolas Maduro, and traders appear to be pricing in potential long-term implications for U.S. oil access and defense spending, even as oil prices themselves have been mixed.Check out this evening's top movers from around Wall Street, compiled by The Fly.HIGHER -Aevaup 26.8% after announcing 4D LiDAR integration within NvidiaDrive HyperionZeta Globalup 8.9% after announcing a strategic collaboration with OpenAIVistraup 4.8% after agreeing to acquire Cogentrix Energy for $4BMicrochipup 3.2% after raising its Q3 revenue guidanceVeevaup 2.1% after announcing a $2B share repurchase programLOWER -Jefferson Capitaldown 4.4% after announcing an offering of 10M shares of common stock for holders
Trade with 70% Backtested Accuracy
Analyst Views on AEVA
About AEVA
About the author

Aeva to Participate in Oppenheimer Conference
- Investor Event: Aeva management will participate in the Oppenheimer 11th Annual Emerging Growth Conference on February 3, 2026, providing an opportunity for engagement with institutional investors to enhance the company's visibility and credibility.
- Technological Vision: Aeva aims to accelerate autonomy across various sectors, including automated driving, manufacturing automation, and smart infrastructure, showcasing its leadership in future technologies.
- Product Advantage: Aeva's 4D LiDAR sensors uniquely detect velocity and position simultaneously, enabling automated devices like vehicles and robots to make more intelligent and safer decisions, thereby enhancing competitiveness in the industry.
- Market Positioning: By collaborating with Oppenheimer, Aeva seeks to further solidify its position in the automation and smart device market, attracting more investments to support its technology development and market expansion.

Valneva SE Withdraws Chikungunya Vaccine Applications, Shares Drop 7.7%
- Vaccine Withdrawal: Valneva SE has withdrawn its BLA and IND applications for the IXCHIQ Chikungunya vaccine due to an FDA suspension and review of new serious adverse events, leading to a 7.7% drop in pre-market trading to $9.29, indicating market concerns over its product prospects.
- Market Decline: U.S. stock futures are broadly lower, with Dow futures falling around 700 points, reflecting investor caution regarding economic outlook, which may impact overall market sentiment and exacerbate volatility in other stocks.
- Other Stock Movements: Shares of Rezolve AI PLC and POET Technologies Inc fell 15% and 11.2% respectively in pre-market trading, indicating widespread investor apprehension towards tech stocks, potentially prompting a reassessment of risk appetite.
- Tesla Update: Tesla's stock fell 2.7% to $425.75 in pre-market trading, despite CEO Elon Musk confirming that vehicles equipped with the AI4 chip will achieve unsupervised autonomous driving, suggesting insufficient market confidence in the electric vehicle sector.






